KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Cash & Current Investments (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Cash & Current Investments for 15 consecutive years, with $308.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 31.95% to $308.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $308.7 million through Dec 2025, down 31.95% year-over-year, with the annual reading at $308.7 million for FY2025, 31.95% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $308.7 million at Supernus Pharmaceuticals, up from $281.2 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $522.6 million in Q2 2025, with the low at $151.7 million in Q2 2023.
  • Average Cash & Current Investments over 5 years is $351.2 million, with a median of $354.0 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments crashed 57.97% in 2023, then soared 128.93% in 2024.
  • Over 5 years, Cash & Current Investments stood at $339.7 million in 2021, then soared by 35.81% to $461.3 million in 2022, then plummeted by 44.75% to $254.9 million in 2023, then surged by 77.97% to $453.6 million in 2024, then crashed by 31.95% to $308.7 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $308.7 million, $281.2 million, and $522.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.